tiprankstipranks
Trending News
More News >
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
US Market

CAMP4 Therapeutics Corporation (CAMP) Ratios

Compare
39 Followers

CAMP4 Therapeutics Corporation Ratios

CAMP's free cash flow for Q4 2025 was $1.00. For the 2025 fiscal year, CAMP's free cash flow was decreased by $ and operating cash flow was $-15.27. See a summary of the company’s cash flow.
Ratios
TTM
Mar 23Mar 22Mar 21Mar 20
Liquidity Ratios
Current Ratio
1.64 2.01 2.00 1.96 4.83
Quick Ratio
1.42 1.80 1.78 1.66 4.44
Cash Ratio
0.39 0.88 0.88 0.88 3.07
Solvency Ratio
-0.03 -0.03 <0.01 -0.13 0.10
Operating Cash Flow Ratio
-0.22 -0.05 0.27 0.10 0.57
Short-Term Operating Cash Flow Coverage
-32.53 -1.63 6.62 0.35 5.42
Net Current Asset Value
$ -191.02M$ -134.80M$ -124.43M$ -120.02M$ 5.52M
Leverage Ratios
Debt-to-Assets Ratio
0.63 0.53 0.47 0.47 0.46
Debt-to-Equity Ratio
16.81 2.73 2.14 1.70 1.34
Debt-to-Capital Ratio
0.94 0.73 0.68 0.63 0.57
Long-Term Debt-to-Capital Ratio
0.94 0.73 0.68 0.59 0.57
Financial Leverage Ratio
26.57 5.19 4.56 3.59 2.94
Debt Service Coverage Ratio
-0.13 0.36 0.89 -0.10 1.89
Interest Coverage Ratio
-3.43 -1.00 -0.25 -0.83 1.18
Debt to Market Cap
0.07 0.04 0.02 0.03 0.03
Interest Debt Per Share
6.83 6.27 6.42 7.61 8.46
Net Debt to EBITDA
719.23 16.88 6.01 8.35 0.41
Profitability Margins
Gross Profit Margin
36.96%41.20%39.67%39.14%40.62%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.09%2.53%5.88%4.16%12.93%
Operating Profit Margin
-7.28%-5.18%-1.25%-4.58%5.41%
Pretax Profit Margin
-10.63%-10.16%-6.67%-15.93%6.56%
Net Profit Margin
-11.02%-10.53%-6.86%-21.52%5.06%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
103.67%103.62%102.72%135.07%77.12%
EBT Per EBIT
145.88%196.31%532.33%347.76%121.12%
Return on Assets (ROA)
-8.55%-7.95%-4.88%-15.89%3.05%
Return on Equity (ROE)
-227.09%-41.31%-22.25%-57.12%8.95%
Return on Capital Employed (ROCE)
-7.85%-5.09%-1.18%-4.48%3.79%
Return on Invested Capital (ROIC)
-8.12%-5.22%-1.20%-5.56%3.93%
Return on Tangible Assets
-12.53%-11.75%-7.01%-22.93%3.87%
Earnings Yield
-0.92%-0.54%-0.23%-1.06%0.17%
Efficiency Ratios
Receivables Turnover
3.56 4.81 4.87 5.07 4.66
Payables Turnover
3.53 5.47 5.21 7.83 5.41
Inventory Turnover
7.78 9.52 7.87 6.06 6.74
Fixed Asset Turnover
6.54 5.92 5.57 4.79 13.46
Asset Turnover
0.78 0.76 0.71 0.74 0.60
Working Capital Turnover Ratio
3.70 2.99 2.76 1.68 1.45
Cash Conversion Cycle
46.08 47.51 51.17 85.70 65.05
Days of Sales Outstanding
102.65 75.93 74.90 72.05 78.34
Days of Inventory Outstanding
46.92 38.33 46.39 60.25 54.12
Days of Payables Outstanding
103.48 66.76 70.12 46.61 67.41
Operating Cycle
149.57 114.26 121.29 132.30 132.46
Cash Flow Ratios
Operating Cash Flow Per Share
-0.64 -0.12 0.84 0.34 1.38
Free Cash Flow Per Share
-0.94 -0.50 0.50 -0.32 1.03
CapEx Per Share
0.31 0.38 0.33 0.66 0.35
Free Cash Flow to Operating Cash Flow
1.48 4.15 0.60 -0.92 0.75
Dividend Paid and CapEx Coverage Ratio
-2.07 -0.32 2.52 0.52 3.98
Capital Expenditure Coverage Ratio
-2.07 -0.32 2.52 0.52 3.98
Operating Cash Flow Coverage Ratio
-0.10 -0.02 0.14 0.05 0.17
Operating Cash Flow to Sales Ratio
-0.08 -0.01 0.09 0.03 0.13
Free Cash Flow Yield
-0.96%-0.31%0.19%-0.14%0.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-109.12 -183.79 -438.48 -94.03 601.05
Price-to-Sales (P/S) Ratio
12.02 19.35 30.06 20.23 30.40
Price-to-Book (P/B) Ratio
247.81 75.92 97.57 53.70 53.77
Price-to-Free Cash Flow (P/FCF) Ratio
-104.18 -326.82 538.45 -695.60 309.46
Price-to-Operating Cash Flow Ratio
-154.60 -1.36K 324.54 641.61 231.63
Price-to-Earnings Growth (PEG) Ratio
-48.01 -4.38 5.97 0.17 47.08
Price-to-Fair Value
247.81 75.92 97.57 53.70 53.77
Enterprise Value Multiple
13.56K 781.07 517.61 495.09 235.42
Enterprise Value
3.74B 5.85B 9.39B 7.53B 11.08B
EV to EBITDA
13.56K 781.07 517.61 495.09 235.42
EV to Sales
12.69 19.78 30.42 20.58 30.45
EV to Free Cash Flow
-110.01 -334.04 544.77 -707.53 310.01
EV to Operating Cash Flow
-163.26 -1.39K 328.35 652.62 232.04
Tangible Book Value Per Share
-2.95 -1.45 -1.08 -0.43 2.25
Shareholders’ Equity Per Share
0.40 2.14 2.79 4.12 5.95
Tax and Other Ratios
Effective Tax Rate
-0.04 -0.04 -0.03 -0.35 -0.06
Revenue Per Share
8.17 8.39 9.04 10.94 10.52
Net Income Per Share
-0.90 -0.88 -0.62 -2.35 0.53
Tax Burden
1.04 1.04 1.03 1.35 0.77
Interest Burden
-----
Research & Development to Revenue
0.08 0.10 0.08 0.08 0.08
SG&A to Revenue
0.18 0.18 0.16 0.16 0.09
Stock-Based Compensation to Revenue
0.03 0.04 0.04 0.03 0.03
Income Quality
0.71 0.14 -1.35 -0.15 2.59
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis